I read post #3 twice before replying, because I had assumed the opposite.
Acetate content: counter-ion content. Trifluoroacetate or acetate from the salt form of the peptide. Affects mass calculations and should be stated on a complete certificate.
I read post #3 twice before replying, because I had assumed the opposite.
Acetate content: counter-ion content. Trifluoroacetate or acetate from the salt form of the peptide. Affects mass calculations and should be stated on a complete certificate.
Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own records is not any individual result; it is that they are dated and consecutive.
post #8 is right about the mechanism and I think understates the practical bit.
For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
Dimer and higher-order multimers: two or more peptide molecules bonded together. They appear at double the mass and higher. They may or may not separate from the monomer on HPLC depending on the method.
I read post #20 twice before replying, because I had assumed the opposite.
Aggregates: multiples of the monomer mass. May not elute at all under a standard reversed-phase method. A species that does not come off the column does not appear in the area percentage.
Oxidation at methionine and tryptophan: adds 16 per oxygen. Usually elutes earlier. Oxidation is common in storage, especially if the solution is exposed to light or if antioxidants are not present.
Truncation products: fragments from incomplete synthesis or from degradation. They elute quite differently from the intact peptide because they are much smaller and have different hydrophobicity. They are usually well separated.
Incomplete deprotection: mass higher by the protecting group mass. Usually markedly later eluting. A synthesis artifact from incomplete removal of protecting groups.
Read the full topic (54 posts)
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
Racemisation and why it is invisible to a mass measurement
Posting this under the heading it deserves: Racemisation and why it is invisible to a mass measurement Everything below is what sits behind that. Working through the identity arithmetic and I would like it…
|
+120 | 127 | 41k | 1mo |
|
Deletion sequences: expected mass shifts by residue
Deletion sequences: expected mass shifts by residue — setting out what I have, and where I think it stops being reliable. Working through the identity arithmetic and I would like it checked. semaglutide has a…
|
2 | 59 | 3mo | |
|
Residual solvents and scavengers: what is looked for — what changed since
Residual solvents and scavengers: what is looked for — what changed since — setting out what I have, and where I think it stops being reliable. Posting the method first, because I know what the first three…
|
+37 | 41 | 7k | 2mo |
|
Aggregates and why a purity assay may miss them entirely
Aggregates and why a purity assay may miss them entirely Writing it up because I had to work it out twice and would rather nobody else did. A documentation question rather than an analytical one. I have a…
|
+61 | 69 | 2.9k | 6mo |
|
About the Impurities & related substances category
Deletion sequences, oxidation, deamidation, aggregates, residual solvents, and counter-ion content. This post is a community wiki: any member at trust level 3 or above can edit it, and every edit is recorded…
|
+6 | 10 | 50k | 15h |
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
Lyophilisation and why the cake looks the way it does
Posting this under the heading it deserves: Lyophilisation and why the cake looks the way it does Everything below is what sits behind that. I would like to understand what this number means before I repeat…
|
+33 | 37 | 60k | 6mo |
|
Oxidation and deamidation mass shifts, tabulated
Posting this under the heading it deserves: Oxidation and deamidation mass shifts, tabulated Everything below is what sits behind that. Working through the identity arithmetic and I would like it checked.…
|
+67 | 76 | 21k | 16mo |
|
Why I ask for the gradient before I discuss the number
The question in the title: Why I ask for the gradient before I discuss the number I will give what I have already checked below so nobody repeats it. I would like to understand what this number means before I…
|
+35 | 39 | 4.9k | 20mo |
|
Cost per delivered dose, which is the number that matters
Cost per delivered dose, which is the number that matters — setting out what I have, and where I think it stops being reliable. A coverage question with the paperwork detail included, since that is what…
|
+54 | 59 | 30k | 4mo |
|
Lean mass preservation: what the evidence supports — does this still hold?
Asking directly, because I could not find a straight answer: Lean mass preservation: what the evidence supports — does this still hold? Maintenance rather than loss, which is the part of this that almost…
|
+112 | 122 | 5.2k | 20h |